Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; povidone; magnesium stearate; hypromellose; microcrystalline cellulose; peg-8 stearate; titanium dioxide; propylene glycol; purified water - treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; povidone; magnesium stearate; hypromellose; microcrystalline cellulose; peg-8 stearate; titanium dioxide; propylene glycol; purified water; iron oxide yellow - treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - citalopram hydrobromide, quantity: 49.98 mg (equivalent: citalopram, qty 40 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; hypromellose; maize starch; lactose monohydrate; purified talc; microcrystalline cellulose; glycerol; macrogol 6000; magnesium stearate; titanium dioxide; copovidone - treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - citalopram hydrobromide, quantity: 24.99 mg (equivalent: citalopram, qty 20 mg) - tablet, film coated - excipient ingredients: maize starch; microcrystalline cellulose; glycerol; hypromellose; titanium dioxide; lactose monohydrate; sodium starch glycollate; magnesium stearate; copovidone; purified talc; macrogol 6000 - treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - escitalopram oxalate, quantity: 25.548 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - escitalopram oxalate, quantity: 12.774 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.

Malta - English - Medicines Authority

accord healthcare ltd - linezolid - film-coated tablet - linezolid 600 meq/ml - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - linezolid - film coated tablet - 600 milligram - linezolid

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - linezolid (form iii) - film coated tablet - 600 milligram - linezolid - antibacterials for systemic use; other antibacterials - linezolid is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: silicon dioxide; sodium stearylfumarate; copovidone; mannitol; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - pharmacor linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,pharmacor linezolid is active against gram-positive bacteria only. pharmacor linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.